The effectiveness and cost-effectiveness of microwave and thermal balloon endometrial ablation for heavy menstrual bleeding: A systematic review and economic modelling

Health Technology Assessment

Volumn 8, Issue 3, 2004, Pages

  Garside, R ^a   Stein, K ^a,c   Wyatt, K ^a,c   Round, A ^a,c   Price, A ^b  

^a UNIVERSITY OF EXETER   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^c UNIVERSITY OF PLYMOUTH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MEFENAMIC ACID; TRANEXAMIC ACID;

ADULT; BALLOON CATHETER; BLEEDING; CATHETER ABLATION; COMPARATIVE STUDY; COST EFFECTIVENESS ANALYSIS; DATA BASE; DEVICE; DIARRHEA; DIZZINESS; ENDOMETRIUM ABLATION; FATIGUE; HEADACHE; HOSPITALIZATION; HUMAN; HYSTERECTOMY; MALE; MENORRHAGIA; MICROWAVE THERAPY; NAUSEA; OPERATION DURATION; OUTCOMES RESEARCH; PATIENT SATISFACTION; PROBABILITY; PUBLICATION; QUALITY ADJUSTED LIFE YEAR; RETROSPECTIVE STUDY; REVIEW; SKIN IRRITATION; SURGICAL TECHNIQUE; VOMITING;

EID: 1242321243     PISSN: 13665278     EISSN: None     Source Type: Journal    
DOI: 10.3310/hta8030     Document Type: Review

References (102)

1. National Statistics Online. Census 2001. http://www.statistics.gov.uk/census2001/pop2001/england_wales.asp.2002.
2. Coulter A, Bradlow J, Agass M, Martin-Bates C, Tulloch A. Outcomes of referrals to gynaecology out-patient clinics for menstrual problems: an audit of general practice records. Br J Obstet Gynaecol 1991;98:789-96.
3. Coulter A, Jenkinson C. Quality of life and patient satisfaction following treatment for menorrhagia. Fam Pract 1994;11:394-401.
4. Rybo G. Clinical and experimental studies on menstrual blood loss. Acta Obstet Gynecol Scand 1966;45:1-23.
5. Royal College of Obstetricians and Gynaecologists. The initial management of menorrhagia. Evidence based guidelines No. 1. London: Royal College of Obstetricans and Gynaecologists; 1998.
6. Chimbira TH, Anderson ABN, Turnbull AC. Study of menstrual blood loss. Br J Obstet Gynaecol 1980;87:603-9.
7. Fraser IS, McCarron G, Markham R. A preliminary study of factors influencing perception of menstrual blood loss volume. Am J Obstet Gynecol 1984;149:788-93.
8. Hallberg L, Hogdahl A, Nilsson L, Rybo G. Menstrual blood loss - a population study. Acta Obstet Gynecol Scand 1966;45:320-51.
9. Lethaby A, Hickey M. Endometrial destruction techniques for heavy menstrual bleeding. Cochrane Database Syst Rev 2002;CD001501. Oxford: Update Software.
10. Kochli OR. Endometrial ablation in the year 2000 - do we have more methods than indications? Contrib Gynecol Obstet 2000;20:91-120.
11. Turnbull AC, Rees MC. Gestrinone in the treatment of menorrhagia. Br J Obstet Gynaecol 1990;97:713-15.
12. Andersson JK, Rybo G. Levonorgestrel-releasing intrauterine device in the treatment of menorrhagia. Br J Obstet Gynaecol 1990;97:690-4.
13. Royal College of Obstetricians and Gynaecologists. The management of menorrhagia in secondary care. Evidence based guidelines No. 5. London: RCOG Press; 1999.
14. Vercellini P, Cortesi I, Oldani S, Morchetta M, De Giorgi O, Crosignani PG. The role of transvaginal ultrasonography in the evaluation of patients with excessive menstrual bleeding. Hum Reprod 1997; 12:1768-71.
15. Bain C, Parkin DE, Cooper KG. Is outpatient diagnostic hysteroscopy more useful than endometrial biopsy alone for the investigation of abnormal uterine bleeding in unselected premenopausal women? A randomised comparison. Br J Obstet Gynaecol 2002;109:805-11.
16. Hallberg L, Nilsson L. Determination of menstrual blood loss. Scand J Clin Lab Invest 1964;16:244-8.
17. Gannon MJ, Day P, Hammadieh N, Johnson N. A new method for measuring menstrual blood loss and its use in screening women before endometrial ablation. Br J Obstet Gynaecol 1996;103:1029-33.
18. Higham JM, O'Brien PM, Shaw RW. Assessment of menstrual blood loss using a pictorial chart. Br J Obstet Gynaecol 1990;97:734-9.
19. Reid PC, Coker A, Coltart R. Assessment of menstrual blood loss using a pictorial chart: a validation study. Br J Obstet Gynaecol 2000;107:320-2.
20. Wyatt KM, Dimmock PW, Walker TJ, O'Brien PMS. Determination of total menstrual blood loss. Fertil Steril 2001;76:125-31.
21. Coulter A, Kelland J, Long A, Melville A, O'Meara S, Sculpher M, et al. The management of menorrhagia. Effective Health Care 1995;9.
22. Hurskaienen R, Teperi J, Turpeinen U, Grenman S, Kivelä A, Kujansuu E, et al. Combined laboratory and diary method for objective assessment of menstrual blood loss. Acta Obstet Gynecol Scand 1998;77:201-4.
23. Royal College of Obstetricians and Gynaecologists. Recommendations arising from the 39th study group: disorders of the menstrual cycle. Disorders of the menstrual cycle. London: RCOG, 2000.
24. Warner P, Critchley OD, Lumsden MA, Campbell-Brown M, Douglas A. Murray G. Referral for menstrual problems: a cross sectional survey of symptoms, reasons for referral and managment. BMJ 2001;323:24-8.
25. Clark TJ, Khan KS, Foon R, Pattison H, Bryan S, Gupta JK. Quality of life instruments in studies of menorrhagia: a systematic review. Eur J Obstet Gynecol Reprod Biol 2002;104:96-104.
26. Lampling DL, Rowe P, Clarke A, Lethaby A. Development and validation of the menorrhagia outcomes questionnaire. Br J Obstet Gynaecol 1998;105:776-9.
27. Shaw RW, Brickley M, Evans L, Edwards M. Perceptions of women on the impact of menorrhagia on their health using multi-attribute utility assessment. Br J Obstet Gynaecol 1998; 105:1155-9.
28. Jenkinson C, Peto V, Coulter A. Measuring change over time: a comparison of results from a global single item of health status and the multi-dimensional SF-36 health status survey questionnaire in patients presenting with menorrhagia. Qual Life Res 1994;3:317-21.
29. Jenkinson C, Peto V, Coulter A. Making sense of ambiguity: evaluation in internal reliability and face validity of the SF-36 questionnaire in women presenting with menorrhagia. Qual Health Care 1996;5:9-12.
30. Sculpher M. A cost-utility analysis of abdominal hysterectomy versus transcervical endometrial resection for the surgical treatment of menorrhagia. Int J Technol Assess Health Care 1998;14:302-19.
31. Weinstein MC. Estrogen use in post-menopausal women - costs, risks and benefits. N Engl J Med 1980;303:308-16.
32. Carter KJ, Ritchey NP, Castro F, Caccamo LP, Kessler E, Erickson BA. Treatment of early stage breast cancer in the elderly: a health outcome-based approach. Med Decis Making 1998;18:213-19.
33. Hillner BE, Smith TJ. Efficacy and cost effectiveness of adjuvant chemotherapy in women with node-negative breast cancer: a decision-analysis model. N Engl J Med 1991;324:160-8.
34. Hillner BE, Hollenberg JP, Pauker SG. Postmenopausal estrogens in prevention of osteoporosis: benefit virtually without risk of cardiovascular effects are considered. Am J Med 1986;80:1115-27.
35. Tsevat J, Goldman L, Lamas GA, Pfeffer MA, Chapin CC, Connors KF, et al. Functional status versus utilities in survivors of myocardial infarction. Med Care 1991;29:1153-9.
36. Brickley M, Kay E, Shepherd JP, Armstrong RA. Decision analysis for lower-third-molar surgery. Med Decis Making 1995;15:143-51.
37. Weinstein MC, Coley CM, Richter JM. Medical management of gallstones: a cost-effectiveness analysis. J Gen Intern Med 1990;5:277-84.
38. Bass EB, Steinberg EP, Pitt HA, Saba GP, Lillemoe KD, Kafonek DR. Cost effectiveness of extracorporeal shock-wave lithotripsy versus cholecystectomy for symptomatic gallstones. Gastroenterology 1991;101:189-99.
39. Dolan P, Kind P. Inconsistency and health state valuations. Soc Sci Med 1996;42:609-15.
40. Crow R, Gage H, Hampson S, Hart J, Kimber A, Storey L, et al. The measurement of satisfaction with health care: implications for practice from a systematic review of the literature. Health Technol Assess 2002;6(32).
41. Coulter A, Kelland J, Peto V, Rees MCP. Treating menorrhagia in primary care: an overview of drug trials and a survey of prescribing practice. Int J Technol Assess Health Care 1995;11:456-71.
42. Prentice, A. AMES study. Presented at the joint BSGE/RCOG conference, Conservative surgery for menorrhagia, London, 17 September 2002.
43. Cooper KG, Jack SA, Parkin DE, Grant AM. Five-year follow up of women randomised to medical management or transcervical resection of the endometrium for heavy menstrual loss: clinical and quality of life outcomes. Br J Obstet Gynaecol 9001;108:1222-8.
44. Department of Health. Hospital episode statistics 2000-1. London: Office for National Statistics; 2002.
45. Bridgman SA, Dunn KM. Has endometrial ablation replaced hysterectomy for the treatment of dysfunctional uterine bleeding? National figures. Br J Obstet Gvnaecol 2000;107:531-4.
46. Farquhar C, Naoom S, Steiner CA. The impact of endometrial ablation on hysterectomy rates in women with benign uterine conditions in the United States. Int J Technol Assess Health Care 2002;18:625-34.
47. Vessey MP, Villard-Mackintosh L, McPherson K, Coulter A, Yeates D. The epidemiology of hysterectomy: findings in a large cohort study. Br J Obstet Gynaecol 1992;99:402-7.
48. Maresh MJA, Metcalfe MA, McPherson K, Overton C, Hall V, Hargreaves J, et al. The VALUE national hysterectomy study: description of the patients and their surgery. Br J Obstet Gynaecol 2002;109:302-12.
49. Farrell SA, Kieser K. Sexuality after hysterectomy Obstet Gynecol 2000;95:1045-51.
50. Brown JS, Sawaya G, Thorn DH, Grady D. Hysterectomy and urinary incontinence: a systematic review. Lancet 2000;356:535-9.
51. Kuh D, Wadsworth M, Hardy R. Women's health in midlife: the influence of the menopause, social factors and health in earlier life. Br J Obstet Gynaecol 1997;104:923-33.
52. Lethaby A, Shepperd S, Cooke I, Farquhar C. Endometrial resection and ablation versus hysterectomy for heavy menstrual bleeding. Cochrane Database Syst Rev 2002;CD000329.
53. Weber AM. Endometrial ablation. Obstet Gynecol 2002;99:969-70.
54. Overton C, Hargreaves J, Maresh M. A national survey of the complications of endometrial destruction for menstrual disorders: the MISTLETOE study. Br J Obstet Gynaecol 1997;104:1351-9.
55. Sowter MC, Lethaby A, Singla AA. Pre-operative endometrial thinning agents before endometrial destruction for heavy menstrual bleeding (Cochrane review). Cochrane Database Syst Rev 2002;CD001124.
56. Vancaillie TG. Electrocoagulation of the endometrium. In Lewis BV, Magos AL, editors. Endometrial ablation. Edinburgh: Churchill Livingstone; 1993, pp. 133-42.
57. Davis JA, Miller CD. Fluid infusion during hysteroscopic surgery. In Lewis BV, Magos AL, editors. Endometrial ablation, Edinburgh: Churchill Livingstone; 1993, pp. 41-56.
58. Garry R. Evidence and techniques in endometrial ablation: consensus. Gynaecol Endosc 2002;11:5-17.
59. Coulter A, Peto V, Doll H. Patients' preferences and general practitioners' decisions in the treatment of menstrual disorders. Fam Pract 1994;11:67-74.
60. Marshall S, Hardy RJ, Kuh D. Socioeconomic variation in hysterectomy up to age 52: national, population based, prospective cohort study. BMJ 2000;320:1579.
61. Cooper KG, Grant AM, Garratt AM. The impact of using a partially randomised patient preference design when evaluating alternative managements for heavy menstrual bleeding. Br J Obstet Gynaecol 1997;104:1367-73.
62. Nagele F, Rubinger T, Magos A. Why do women choose endometrial ablation rather than hysterectomy? Fertil Steril 1998;69:1063-6.
63. Sculpher M, Dwyer N, Browning J, Horsley S, Cullimore J. A survey of women's preferences regarding alternative surgical treatments for menorrhagia. Health Expect 1998;1:96-105.
64. Sharp NC, Cronin N, Feldberg I, Evans M, Hodgson D, Ellis S. Microwaves for menorrhagia: a new fast technique for endometrial ablation. Lancet 1995;346:1003-4.
65. Hodgson DA, Feldberg IB, Sharp N, Cronin N, Evans M, Hirschowitz L. Microwave endometrial ablation: development, clinical trials and outcomes at three years. Br J Obstet Gynaecol 1999;106:684-94.
66. Bongers MY, Mol B-WJ, Brolmann H-AM. Prognostic factors for the success of thermal balloon ablation in the treatment of menorrhagia. Obstet Gynecol 2002;99:1060-6.
67. Bain C, Cooper KG, Parkin DE. A partially randomized patient preference trial of microwave endometrial ablation using local anaesthesia and intravenous sedation or general anaesthesia: a Pilot Study. Gynaecol Endosc 2001;10:223-8.
68. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF, et al. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Lancet 1999; 354:1896-900.
69. The Government Actuary Department. Interim life tables - expectation of life for England and Wales Females 1998-2000. London: The Government Actuary Department; 2002.
70. MacLean-Fraser E, Penava D, Vilos GA. Perioperative complication rates of primary and repeat hysteroscopic endometrial ablations. J Am Assoc Gynecol Laparosc 2002;9:175-7.
71. Rogerson L, Duffy S. A European survey of the complications of a uterine thermal balloon system in 5800 women. Gynaecol Endosc 2002;11:171.
72. Parkin DE. Microwave endometrial ablation (MEA™): a safe technique? Complication data from a prospective series of 1400 cases. Gynaecol Endosc 2000;9:385-8.
73. Department of Health. Hospital episode statistics 2000-1. London: Office for National Statistics; 2002.
74. Sculpher M, Fenwick E, Claxton K. Assessing quality in decision analytic cost-effectiveness models: a suggested framework and example of application. Pharmacoeconomics 2000;17:461-77.
75. Drummond MF, O'Brien B, Stoddart GL, Torrance GW, Methods for the economic evaluation of health care programmes. Oxford: Oxford University Press; 1997.
76. Iyer V, Farquhar C, Jepson R. Oral contraception pills for heavy menstrual bleeding. Cochrane Library 2002;4.
77. Lethaby A, Irvine G, Cameron IM. Cyclical progestogens for heavy menstrual bleeding (Cochrane review). Cochrane Library 2002;4. Oxford: Update Software.
78. Beaumont H, Augood C, Duckitt K, Lethaby A. Danazol for heavy menstrual bleeding (Cochrane review). Cochrane Library 2002;4. Oxford: Update Software.
79. Lethaby A, Augood C, Duckitt K. Nonsteroidal anti-inflammatory drugs for heavy menstrual bleeding (Cochrane review). Cochrane Library 2002;4. Oxford: Update Software.
80. Lethaby A, Farquhar C, Cooke I. Antifibrinolytics for heavy menstrual bleeding (Cochrane review). Cochrane Database Syst Rev 2002. Oxford: Update Software.
81. Lethaby AE, Cooke I, Rees M. Progesterone/progestogen releasing intrauterine systems versus either placebo or any other medication for heavy menstrual bleeding. Cochrane Database Syst Rev 2000;CD002126. Oxford: Update Software.
82. Meyer WR, Walsh BW, Grainger DA, Peacock LM, Loffer FD, Steege JF. Thermal balloon and rollerball ablation to treat menorrhagia: a multicenter comparison. Obstet Gynecol 1998; 92:98-103.
83. Romer T. Therapy of recurrent menorrhagia - Cavaterm balloon coagulation versus roller-ball endometrium coagulation - a prospective randomized comparative study. Zentralbl Gynakol 1998;120:511-14.
84. Grainger DA, Tjaden BL, Rowland C, Meyer WR. Thermal balloon and rollerball ablation to treat menorrhagia: two-year results of a multicenter, prospective, randomized, clinical trial. J Am Assoc Gynecol Laparosc 2000;7:175-9.
85. Loffer FD. Three-year comparison of thermal balloon and rollerball ablation in treatment of menorrhagia. J Am Assoc Gynecol Laparosc 2001; 8:48-54.
86. Cooper KG, Bain C, Parkin DE. Comparison of microwave endometrial ablation and transcervical resection of the endometrium for treatment of heavy menstrual loss: a randomised trial. Lancet 1999;354:1859-63.
87. Bain C, Cooper KG, Parkin DE. Microwave endometrial ablation versus endometrial resection: a randomized controlled trial. Obstet Gynecol 2002;99:983-7.
88. Microsulis Americas. Microwave endometrial ablation. FDA trial. Coral Springs, FL: Microsulis Americas; 2002.
89. Bongers MY, Mol BW, Dijkhuizen FP, Brolmann HA. Is balloon ablation as effective as endometrial electroresection in the treatment of menorrhagia? J Laparoendosc Adv Surg Tech A 2000;10:85-92.
90. Gervaise A, Fernandez H, Capella-Allouc S, Taylor S, La Vieille S, Hamou J, et al. Thermal balloon ablation versus endometrial resection for the treatment of abnormal uterine bleeding. Hum Reprod 1999;14:2743-7.
91. Soysal ME, Soysal SK, Vicdan K. Thermal balloon ablation in myoma-induced menorrhagia under local anesthesia. Gynecol Obstet Invest 2001; 51:128-33.
92. Pellicano M, Guida M, Acunzo G, Cirillo D, Bifulco G, Nappi C. Hysteroscopic transcervical endometrial resection versus thermal destruction for menorrhagia: a prospective randomized trial on satisfaction rate. Am J Obstet Gynecol 2002; 187:545-50.
93. Zon-Rabelink I. Rollerball versus Thermachoice. 10th Congress of the European Society for Gynaecological Endoscopy, Proceedings 2001; 11-14.
94. Loffer FD,.Grainger D. Five-year follow-up of patients participating in a randomized trial of uterine balloon therapy versus rollerball ablation for treatment of menorrhagia. J Am Assoc Gynecol Laparosc 2002;9:429-35.
95. Loffer FD. Three-year comparison of thermal balloon rollerball ablation in treatment of menorrhagia (vol 8, pg 48, 2001). J Am Assoc Gynecol Laparosc 2001;8:330.
96. Brun JL, et al. French randomised comparative multicentre study of Cavaterm™ versus resection in patients with meorrhagia: interim results. Morges, Switzerland: Wallsten Medical SA; 2002.
97. Pinion SB, Parkin DE, Abramovich DR, Naji A, Alexander DA, Russell IT, et al. Randomised trial of hysterectomy, endometrial laser ablation, and transcervical endometrial resection for dysfunctional uterine bleeding. BMJ 1994; 309:979-83.
98. Bae IH, Pagedas AC, Perkins HE, Bae DS. Postablation-tubal sterilization syndrome. J Am Assoc Gynecol Laparosc 1996;3:435-8.
99. McCausland AM, McCausland VM. Frequency of symptomatic cornual hematometra and postablation tubal sterilization syndrome after total rollerball endometrial ablation: a 10-year follow-up. Am J Obstet Gynecol 2002;186:1274-80.
100. Overton C, Hargreaves J, Maresh M. A national survey of the complications of endometrial destruction for menstrual disorders: the MISTLETOE study. Contemp Rev Obstet Gynaecol 1998;10:209-16.
101. Amso NN, Stabinsky SA. McFaul P, Blanc B, Pendley L, Neuwirth R. Uterine thermal balloon therapy for the treatment of menorrhagia: the first 300 patients from a multi-centre study. International Collaborative Uterine Thermal Balloon Working Group. Br J Obstet Gynaecol 1998;105:517-23.
102. O'Connor H, Broadbent JA, Magos AL, McPherson K. Medical Research Council randomised trial of endometrial resection versus hysterectomy in management of menorrhagia. Lancet 1997;349:897-901